APT in the Dairy Farm
Normalizing SCC, Improved Milk Yield and Quality, and Reduced Culling
The treatment program recommended by Armenta was developed based on two decades of APT use among human patients and validating testing on 10’s of dairy herds.
- Tested in
17 Countries - Over
2 Years - 2100
Dairy cows - Read +
the academic paper
According to the farmers and veterinarians involved in these treatments,
the APT equipment was extremely user-friendly and comfortable, and it performed very well. The treatments were simple to administer, and the animals displayed no resistance, remaining calm for the duration of the treatment. The unprecedented improvements in productivity and animal welfare meant an 80% reduction in culling rates, and a measurable and rapid improvement in farm profitability.
Higher milk Quality Dramatically reduced SCC levels
397 cows
with sub-clinial mastitis
APT treatment group
(n = 311)
Untreated control group
(n = 86)
68 cows
with clinical mastitis
APT treatment group
(n = 32)
Antibiotics group
(n = 36)
*Recovered = SCC (somatic cell count) < 300,000 cell/ml
>70% curing the inflammation
regardeless Clinical or Sub-Clinical Mastitis
Higher milk Yield
Increased milk production and quality
206 cows
with sub-clinial mastitis
APT treatment group
(n = 163)
Untreated control group
(n = 43)
46 cows
with clinical mastitis
APT treatment group
(n = 13)
Antibiotics group
(n = 33)
*Day in milk was similar in both groups
*Day in milk was similar in both groups
>10% increase in daily milk yield over no treatment
>30% in total milk production
Lower Culling Rates
75 cows
identified with clinical mastitis (visually or due to SCC elevations > 1M cell/ml)
APT treatment group
(n = 15)
Antibiotics group
(n = 44)
Control
(n = 16)
Using APT;
over 80% decrease in culling rates